The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT
- PMID: 11748260
- PMCID: PMC209470
- DOI: 10.1172/JCI13827
The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT
Abstract
Costimulatory molecules on antigen-presenting cells (APCs) play an important role in T cell activation and expansion. However, little is known about the surface molecules involved in direct T-T cell interaction required for their activation and expansion. LIGHT, a newly discovered TNF superfamily member (TNFSF14), is expressed on activated T cells and immature dendritic cells. Here we demonstrate that blockade of LIGHT activity can reduce anti-CD3-mediated proliferation of purified T cells, suggesting that T cell-T cell interaction is essential for this proliferation. To test the in vivo activity of T cell-derived LIGHT in immune homeostasis and function, transgenic (Tg) mice expressing LIGHT in the T cell lineage were generated. LIGHT Tg mice have a significantly enlarged T cell compartment and a hyperactivated peripheral T cell population. LIGHT Tg mice spontaneously develop severe autoimmune disease manifested by splenomegaly, lymphadenopathy, glomerulonephritis, elevated autoantibodies, and severe infiltration of various peripheral tissues. Furthermore, the blockade of LIGHT activity ameliorates the severity of T cell-mediated diseases. Collectively, these findings establish a crucial role for this T cell-derived costimulatory ligand in T cell activation and expansion; moreover, the dysregulation of T cell-derived LIGHT leads to altered T cell homeostasis and autoimmune disease.
Figures








Comment in
-
Turning on LIGHT.J Clin Invest. 2001 Dec;108(12):1741-2. doi: 10.1172/JCI14651. J Clin Invest. 2001. PMID: 11748255 Free PMC article. No abstract available.
Similar articles
-
Turning on LIGHT.J Clin Invest. 2001 Dec;108(12):1741-2. doi: 10.1172/JCI14651. J Clin Invest. 2001. PMID: 11748255 Free PMC article. No abstract available.
-
The role of LIGHT in T cell-mediated immunity.Immunol Res. 2004;30(2):201-14. doi: 10.1385/IR:30:2:201. Immunol Res. 2004. PMID: 15477661 Review.
-
The critical role of LIGHT, a TNF family member, in T cell development.J Immunol. 2001 Nov 1;167(9):5099-105. doi: 10.4049/jimmunol.167.9.5099. J Immunol. 2001. PMID: 11673520
-
Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction.J Immunol. 2001 Dec 1;167(11):6330-7. doi: 10.4049/jimmunol.167.11.6330. J Immunol. 2001. PMID: 11714797
-
Lymphotoxin and LIGHT signaling pathways and target genes.Immunol Rev. 2004 Dec;202:49-66. doi: 10.1111/j.0105-2896.2004.00206.x. Immunol Rev. 2004. PMID: 15546385 Review.
Cited by
-
CD160 serves as a negative regulator of NKT cells in acute hepatic injury.Nat Commun. 2019 Jul 22;10(1):3258. doi: 10.1038/s41467-019-10320-y. Nat Commun. 2019. PMID: 31332204 Free PMC article.
-
An engineered novel lentivector specifically transducing dendritic cells and eliciting robust HBV-specific CTL response by upregulating autophagy in T cells.Cell Cycle. 2018;17(10):1220-1234. doi: 10.1080/15384101.2018.1471312. Epub 2018 Jul 18. Cell Cycle. 2018. PMID: 30019620 Free PMC article.
-
Serum Immune Profiling in Paediatric Crohn's Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments.J Crohns Colitis. 2023 Aug 21;17(8):1262-1277. doi: 10.1093/ecco-jcc/jjad049. J Crohns Colitis. 2023. PMID: 36934327 Free PMC article. Clinical Trial.
-
Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling.J Leukoc Biol. 2011 Apr;89(4):517-23. doi: 10.1189/jlb.0910528. Epub 2010 Nov 24. J Leukoc Biol. 2011. PMID: 21106644 Free PMC article. Review.
-
Aberrant Expressions of Co-stimulatory and Co-inhibitory Molecules in Autoimmune Diseases.Front Immunol. 2019 Feb 20;10:261. doi: 10.3389/fimmu.2019.00261. eCollection 2019. Front Immunol. 2019. PMID: 30842773 Free PMC article.
References
-
- Fu YX, Chaplin DD. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol. 1999;17:399–433. - PubMed
-
- Ware CF, VanArsdale TL, Crowe PD, Browning JL. The ligands and receptors of the lymphotoxin system. Curr Top Microbiol Immunol. 1995;198:175–218. - PubMed
-
- Sedgwick JD, Riminton DS, Cyster JG, Korner H. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today. 2000;21:110–113. - PubMed
-
- Ruddle NH. Lymphoid neo-organogenesis: lymphotoxin’s role in inflammation and development. Immunol Res. 1999;19:119–125. - PubMed
-
- Wang Y, Wang J, Sun Y, Wu Q, Fu YX. Complementary effects of TNF and lymphotoxin on the formation of germinal center and follicular dendritic cells. J Immunol. 2001;166:330–337. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous